Sean McCarthy
Board Member
CytomX Therapeutics, Inc. (CTMX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Sean McCarthy
Sean McCarthy is recorded as Board Member and CEO at CytomX Therapeutics, Inc. (CTMX). The proxy statement of CytomX Therapeutics, Inc. reports total compensation of $2,611,138 for Sean McCarthy in fiscal 2023, including a base salary of $652,088. Disclosed compensation is on record for 7 fiscal years. Sean McCarthy has spoken on 23 earnings calls and 4 other investor events across 1 company, most recently for CytomX Therapeutics, Inc. on September 8, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at CytomX Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Chris Ogden CFO, Chief Accounting Officer
- Amy Peterson COO
- Lloyd A. Rowland General Counsel
- Alan Ashworth Board Member
- Alan Ashworth, Ph.D., FRS Board Member
- Charles Fuchs, M.D., M.P.H. Board Member
- Elaine V. Jones Board Member
- Elaine V. Jones Ph.D Board Member
- Elaine V. Jones Ph.D. Board Member
- Halley Gilbert Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | CytomX Therapeutics, Inc. (CTMX) | D. Phil. Chief Executive Officer and Chairman of the Board of Directors | $652,088 | $2,611,138 |
| 2022 | CytomX Therapeutics, Inc. (CTMX) | D. Phil. Chief Executive Officer and Chairman of the Board of Directors | $622,893 | $3,013,606 |
| 2021 | CytomX Therapeutics, Inc. (CTMX) | D. Phil. Chief Executive Officer and Chairman of the Board of Directors | $615,825 | $4,339,415 |
| 2020 | CytomX Therapeutics, Inc. (CTMX) | D. Phil. Chief Executive Officer and Chairman of the Board of Directors | $595,000 | $2,849,850 |
| 2019 | CytomX Therapeutics, Inc. (CTMX) | D. Phil. Chief Executive Officer and Chairman of the Board of Directors | $575,000 | $3,769,930 |
| 2018 | CytomX Therapeutics, Inc. (CTMX) | D. Phil. President, Chief Executive Officer and Chairman of the Board of Directors | $550,000 | $5,482,233 |
| 2017 | CytomX Therapeutics, Inc. (CTMX) | D. Phil. President, Chief Executive Officer and Chairman of the Board of Directors | $500,000 | $3,213,339 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.